MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3)

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Verma R, Sharma PC. Next generation sequencing-based emerging trends in molecular biology of gastric cancer. Am J Cancer Res. 2018 Feb 1;8(2):207–225.
   PubMed Web of Science ®Google Scholar
• Ding L, Zhao Y, Dang S, et al. RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4. Mol Cancer. 2019 Mar 28;18(1):45.
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015 Mar 14;385(9972):977–1010.
   PubMed Web of Science ®Google Scholar
• Takahashi RU, Prieto-Vila M, Hironaka A, et al. The role of extracellular vesicle microRNAs in cancer biology. Clin Chem Lab Med. 2017 May 1;55(5):648–656.
   PubMed Web of Science ®Google Scholar
• Small HK. RNAs are raising big expectations. J Natl Cancer Inst. 2009 Jun 16;101(12):840–841.
   PubMedGoogle Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017 Mar;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Hu S, Zheng Q, Wu H, et al. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci. 2017 May 15;177(15–19). DOI:10.1016/j.lfs.2017.03.019.
   Google Scholar
• Zhao L, Xue M, Zhang L, et al. MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer. Cancer Gene Ther. 2020 Jun;27(6):461–472.
   PubMed Web of Science ®Google Scholar
• Kong XX, Lv YR, Shao LP, et al. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells. J Transl Med. 2016 Jun 27;14(1):189.
   PubMedGoogle Scholar
• Yang W, Xiao W, Cai Z, et al. miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway. Onco Targets Ther. 2020 Jan 7;13:109–118. .
   PubMed Web of Science ®Google Scholar
• Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014 May;15(5):313–326.
   PubMed Web of Science ®Google Scholar
• Deng X, Su R, Feng X, et al. Role of N6-methyladenosine modification in cancer. Curr Opin Genet Dev. 2018 Feb;48:1–7.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yin Z, Hou B, et al. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Cancer Manag Res. 2019 May 1;11:3921–3931. .
   PubMed Web of Science ®Google Scholar
• Choe J, Lin S, Zhang W, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 2018 Sep;561(7724):556–560.
   PubMed Web of Science ®Google Scholar
• Yue B, Song C, Yang L, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019 Oct 13;18(1):142.
   PubMed Web of Science ®Google Scholar
• Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014 Jan;17(1):26–33.
   PubMed Web of Science ®Google Scholar
• Ji B, Huang Y, Gu T, et al. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer. Cancer Biomark. 2019;24(2):249–255.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Ren LF, Wang HP, et al. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. World J Gastroenterol. 2019 Apr 7;25(13):1580–1591.
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004 Jul;5(7):522–531.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu X, Guo L, et al. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer. FEBS Open Bio. 2019 Nov;9(11):1983–1993. .
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Ea M, et al. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 9;435(7043):834–838.
   PubMed Web of Science ®Google Scholar
• Necula L, Matei L, Dragu D, et al. Recent advances in gastric cancer early diagnosis. World J Gastroenterol. 2019 May 7;25(17):2029–2044.
   PubMed Web of Science ®Google Scholar
• Tang J, Hu Y, Zhang C, et al. miR-4636 inhibits tumor cell proliferation, migration and invasion, and serves as a candidate clinical biomarker for gastric cancer. Oncol Lett. 2021 Jan;21(1):33.
   PubMed Web of Science ®Google Scholar
• Zk Q, Liu N, Sf Z, et al. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer. Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1672–1679.
   PubMed Web of Science ®Google Scholar
• Qian Y, Wu X, Wang H, et al. MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin. Braz J Med Biol Res. 2020 Apr 17;53(5):e9330.
   PubMed Web of Science ®Google Scholar
• Mei JW, Yang ZY, Xiang HG, et al. MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer. 2019 Jul 29;19(1):740.
   PubMedGoogle Scholar
• Bao C, Guo L. MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer. J Clin Lab Anal. 2020 Oct;34(10):e23454.
   PubMed Web of Science ®Google Scholar
• Kang W, Huang T, Zhou Y, et al. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Cell Death Dis. 2018 Jan 24;9(2):92.
   PubMed Web of Science ®Google Scholar
• Abdi S, Zamanian Azodi M, Rezaei-Tavirani M, et al. Differentiation of H. pylori-negative and positive gastric cancer via regulatory network analysis. Gastroenterol Hepatol Bed Bench. 2020;13(2):161–167. Spring
   PubMedGoogle Scholar
• Wu KZ, Zhang CD, Zhang C, et al. miR-665 Suppresses the Epithelial-Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1. Cancer Manag Res. 2020 May 15;12:3489–3501. .
   PubMed Web of Science ®Google Scholar
• Chen L, Liu D, Yi X, et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway. Cell Death Dis. 2020 May 5;11(5):320.
   PubMed Web of Science ®Google Scholar
• Bokar JA, Shambaugh ME, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997 Nov;3(11):1233–1247.
   PubMed Web of Science ®Google Scholar
• Leach RA, Tuck MT. Expression of the mRNA (N6-adenosine)-methyltransferase S-adenosyl-L-methionine binding subunit mRNA in cultured cells. Int J Biochem Cell Biol. 2001 Oct;33(10):984–999.
   PubMed Web of Science ®Google Scholar
• Wang X, Feng J, Xue Y, et al. Corrigendum: structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature. 2017 Feb 9;542(7640):260.
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, et al. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016 May 5;62(3):335–345.
   PubMed Web of Science ®Google Scholar
• Wang H, Xu B, Shi J. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2020 Jan 5;722:144076. .
   PubMed Web of Science ®Google Scholar
• Peng W, Li J, Chen R, et al. METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway. J Exp Clin Cancer Res. 2019 Sep 6;38(1):393.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen C, Ding Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020 Jul;69(7):1193–1205.
   PubMed Web of Science ®Google Scholar
• Du M, Zhang Y, Mao Y, et al. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem Biophys Res Commun. 2017 Jan 22;482(4):582–589.
   PubMed Web of Science ®Google Scholar
• Wei W, Huo B, Shi X. miR-600 inhibits lung cancer via downregulating the expression of METTL3. Cancer Manag Res. 2019 Feb 1;11(1177–1187). DOI:10.2147/CMAR.S181058.
   Google Scholar
• He H, Wu W, Sun Z, et al. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62. Biochem Biophys Res Commun. 2019 Oct 1;517(4):581–587.
   PubMed Web of Science ®Google Scholar